SiBionics Archives - Medical Design Sourcing

The FreeStyle Libre 3 continuous glucose monitor. [Image courtesy of Abbott]Abbott (NYSE:ABT) filed three patent lawsuits against SiBionics and its distribution partner in Europe, JUVE-Patent reports.

The lawsuits include patent infringement allegations centered around continuous glucose monitoring (CGM) devices, according to the report. Abbott filed them against China-based SiBionics and its sales partner Umedwings at the Unified Patent Court.

SiBionics develops, manufactures and distributes CGM and other monitoring technologies. It received CE mark approval for its GS1 continuous glucose monitoring (CGM) system last fall. Umedwings, a Dutch company, serves as its distribution partner in Europe.

Get the full story at our sister site, Drug Delivery Business News.

The GS1 CGM. [Image from SiBionics]SiBionics announced today that it received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system.

The company designed its CGM system to provide healthcare providers and patients with data necessary for maintaining glucose control. It offers 14 days of calibration-free continuous glucose monitoring and can transmit data to monitoring devices or mobile applications.

GS1 not only supports data sharing with friends and family but integrates the ProView remote access platform. ProView allows healthcare providers to remotely monitor and provide timely medical interventions.

Get the full story at our sister site, Drug Delivery Business News.

SiBionics

Report: Abbott files trio of patent lawsuits over CGM tech in Europe

SiBionics wins CE mark for 14-day CGM